Activation of Bivalent Gene POU4F1 Promotes and Maintains Basal‐like Breast Cancer
Advanced Science · 2024
DOI: 10.1002/advs.202307660 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Jiahui Zhang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Breast…. Hauptthemen laut MEDLINE: Breast Neoplasms, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
Basal‐like breast cancer (BLBC) is the most aggressive molecular subtype of breast cancer with worse prognosis and fewer treatment options. The underlying mechanisms upon BLBC transcriptional dysregulation and its upstream transcription factors (TFs) remain unclear. Here, among the hyperactive candidate TFs of BLBC identified by bioinformatic analysis, POU4F1 is uniquely upregulated in BLBC and is associated with poor prognosis. POU4F1 is necessary for the tumor growth and malignant phenotypes of BLBC through regulating G1/S transition by direct binding at the promoter of CDK2 and CCND1. More importantly, POU4F1 maintains BLBC identity by repressing ERα expression through CDK2‐mediated EZH2 phosphorylation and subsequent H3K27me3 modification in ESR1 promoter. Knocking out POU4F1 in BLBC cells reactivates functional ERα expression, rendering BLBC sensitive to tamoxifen treatment. In‐depth epigenetic analysis reveals that the subtype‐specific re‐configuration and activation of the bivalent chromatin in the POU4F1 promoter contributes to its unique expression in BLBC, which is maintained by DNA demethylase TET1. Together, these results reveal a subtype‐specific epigenetically activated TF with critical role in promoting and maintaining BLBC, suggesting that POU4F1 is a potential therapeutic target for BLBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University,…
- Department of Plastic Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.
- Center for Biotherapy, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.
- Cellular & Molecular Diagnostics Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.
Förderung
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
Zitieren
APA
Zhang, J., Miao, N., Lao, L., Deng, W., Wang, J., Zhu, X., Huang, Y., Lin, H., Zeng, W., Zhang, W., Tan, L., Yuan, X., Zeng, X., Zhu, J., Chen, X., Song, E., Yang, L., Nie, Y., & Huang, D. (2024). Activation of Bivalent Gene POU4F1 Promotes and Maintains Basal‐like Breast Cancer. Advanced Science. https://doi.org/10.1002/advs.202307660
Vancouver
Zhang J, Miao N, Lao L, Deng W, Wang J, Zhu X, et al. Activation of Bivalent Gene POU4F1 Promotes and Maintains Basal‐like Breast Cancer. Advanced Science. 2024. doi:10.1002/advs.202307660
BibTeX
@article{Zhang2024,
author = {Zhang, Jiahui and Miao, Nanyan and Lao, Liyan and Deng, Wen and Wang, Jiawen and Zhu, Xiaofeng and Huang, Yongsheng and Lin, Huayue and Zeng, Wenfeng and Zhang, Wei and Tan, Luyuan and Yuan, Xiaoqing and Zeng, Xin and Zhu, Jingkun and Chen, Xueman and Song, Erwei and Yang, Linbin and Nie, Yan and Huang, Di},
title = {Activation of Bivalent Gene POU4F1 Promotes and Maintains Basal‐like Breast Cancer},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202307660}
}
EUVIMED